Androgens and hypertension: Role in both males and females?

Hypertension

Volumn 57, Issue 4, 2011, Pages 681-682

  Reckelhoff, Jane F ^a   Roman, Richard J ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

20 HYDROXY 5,8,11,14 EICOSATETRAENOIC ACID; ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; CYTOCHROME P450 4A; ESTRADIOL; ICOSATETRAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PARTHENOLIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TESTOSTERONE; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; DRUG ACTIVITY; EDITORIAL; ESTRADIOL BLOOD LEVEL; HUMAN; HYPERTENSION; MENOPAUSE; NONHUMAN; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; TESTOSTERONE BLOOD LEVEL; UPREGULATION;

ANDROGENS; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; MALE; SEX CHARACTERISTICS;

EID: 79953215581     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.162750     Document Type: Editorial

References (12)

1. Reckelhoff JF, Fortepiani LA. Novel mechanisms responsible for postmenopausal hypertension. Hypertension. 2004;43:918-923. (Pubitemid 38579888)
2. Diamanti-Kandarakis E. Polycystic ovarian syndrome; pathophysiology, molecular aspects and clinical implications. Exp Rev Mol Med. 2008;10:1-21. (Pubitemid 351338213)
3. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, von Muhlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Endocrinol Metabol. 2000;85:645-651. (Pubitemid 32273648)
4. Wu C-C, Cheng J, Zhang FF, Gotlinger KH, Kelkar M, Zhang Y, Jat JL, Falck JR, Schwartzman ML. Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of-B kinase. Hypertension. 2011; 57:788-794.
5. Nakagawa K, Marji J, Schwartzman M, Waterman M, Capdevila J. Androgen-mediated induction of the kidney arachidonate hydroxylasses is associated with the development of hypertension. Am J Physiol Regul Integr Comp Physiol. 2003;284:R1055-R1062. (Pubitemid 36406866)
6. Singh H, Cheng J, Deng H, Kemp R, Ishizuka T, Nasjletti A, Schwartzman ML. Vascular cytochorme p450 4a expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunciton in androgen-induced hypertension. Hypertension. 2007;50:123-129. (Pubitemid 46986020)
7. Ishizuka T, Cheng J, Singh H, Vitto MD, Manthati VL, Falck JR, Schwartzman ML. 20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappab activation and the production of inflammatory cytokines in human endothelial cells. J Pharmacol Exp Ther. 2008;324:103-110. (Pubitemid 350294158)
8. Delfino F, Boustead J, Fix C, Walker W. Nf-kappab and TNF-stimulate androgen receptor expression in sertoli cells. Mol Cell Endocrinol. 2003; 201:1-12.
9. Culig Z. Androgen receptor cross-talk with cell-signalling pathways. Growth Factors. 2004;22:179-184. (Pubitemid 39377910)
10. Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, Jones TH. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab. 2004;89:3313-3318. (Pubitemid 38951897)
11. Shabsigh R, Arver K, Channer KS, Eardley I, Fabbri A, Gooren LJ, Heufelder A, Haider J, Jones H, Meryn S, Zitzman M. The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. Int J Clin Prac. 2008;62:791-798. (Pubitemid 351533668)
12. Singh H, Schwartzman ML. Renal vascular cytochrome p450-derived eicosanoids in androgen-induced hypertension. Pharmacol Rep. 2008;60:29-37. (Pubitemid 351586540)